Ionis Pharmaceuticals (IONS) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -657.1 | 2.76 | 3.72 | -12.3 | -43.9 | 2.71 | ||
| Changes by years, y/y, % | +957% | -100% | +35% | -430% | +258% | -6.7% | |||
Ionis Pharmaceuticals. EV/EBITDA
Ionis Pharmaceuticals. EV/EBITDA, changes, %
Ionis Pharmaceuticals (IONS) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -12.9 | -32.3 | -63.6 | 2.81 | 2.73 | 2.71 | |
| Changes by years, y/y, % | -1 348% | +221% | -121% | -121% | ||||
| Changes by quarters, q/q, % | -2% | +150% | +97% | -104% | -3% | |||